162648-32-0

Basic information

• Product Name: 4-Piperidinecarboxylicacid,4-methyl-(9CI)
• Synonyms: 4-Piperidinecarboxylicacid,4-methyl-(9CI);4-methyl-4-piperidinecarboxylic acid(SALTDATA: HCl);4-Methyl-4-piperidinecarboxylic acid;4-Methylpiperidine-4-carboxylic acid hydrochloride;4-Methylpiperidine-4-carboxylic acid;4-Methylisonipecotic acid
• CAS NO: 162648-32-0
• Molecular Formula: C7H14ClNO2
• Molecular Weight: 179.64456
• Product Categories: CARBOXYLICACID
• Mol File: 162648-32-0.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 259.5±33.0℃ (760 Torr)
• Flash Point: 110.7±25.4℃
• Appearance: /
• Density: 1.075±0.06 g/cm3 (20 ºC 760 Torr)
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• CAS DataBase Reference: 4-Piperidinecarboxylicacid,4-methyl-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Piperidinecarboxylicacid,4-methyl-(9CI)(162648-32-0)
• EPA Substance Registry System: 4-Piperidinecarboxylicacid,4-methyl-(9CI)(162648-32-0)

Safety Data

• Hazard Codes: Xn
• Statements: 22-36/37/38
• Safety Statements: 26
• HazardClass: IRRITANT
• Hazardous Substances Data: 162648-32-0(Hazardous Substances Data)

Usage

Uses

4-Methylpiperidine-4-carboxylic Acid Hydrochloride is used in preparation of substituted aminoquinolones as DGKα inhibitors for immune activation.

Upstream product

• 189321-63-9 1-(tert-butoxycarbonyl)-4-methylpiperidine-4-carboxylic acid 
• 892493-16-2 4-methyl-piperidine-4-carboxylic acid methyl ester 
• 162648-31-9 1-benzoyl-4-methylpiperidine-4-carboxylic acid 
• 439944-43-1 ethyl 1-methoxycarbonyl-4-piperidinecarboxylate 
• 439944-44-2 ethyl 1-methoxycarbonyl-4-methyl-4-piperidinecarboxylate 
• 189442-87-3 ethyl tert-butyl 4-methylpiperidine-1,4-dicarboxylate 

Downstream Products

• 189321-63-9 1-(tert-butoxycarbonyl)-4-methylpiperidine-4-carboxylic acid 
• 162648-33-1 1,4-dimethylpiperidine-4-carboxylic acid 

Relevant articles and documents

PYRAZOLOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY

A series of substituted pyrazolo[1,5-a]pyridine derivatives, being potent modulators of human TNFα activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.

NOVEL BENZAMIDINE COMPOUND

A novel compound, or a pharmaceutically acceptable salt thereof, represented by the formula (1) wherein the characters are as defined in the description. Thus, there can be provided an activated blood coagulation factor X inhibitor and a novel anti(blood)

Hindered esters of rapamycin

A compound of the structure STR1 wherein R and R1 are each, independently, STR2 or hydrogen; R2 and R3 are each, independently, alkyl, arylalkyl, or R2 and R3 may be taken together to form a cycloalky